Glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors prevent platelet aggregation by blocking glycoprotein IIb/IIIa receptors on their platelet's plasma membrane and inhibiting fibrinogen binding. The available GP IIb/IIIa inhibitors include tirofiban and eptifibatide. These agents, along with aspirin, are used in patients with unstable angina with PCI within 24 hours.
Copyright © 2024, StatPearls Publishing LLC.